USPTO serial 79103548
VELOXIS PHARMACEUTICALS
Reviewed by CopyMark Law Group
Reg. 4212076Status 707Registered
- Filing date
- Status date
- Registration date
- Sep 25, 2012
- Examiner
- EINSTEIN, MATTHEW T
- Law office
- —
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with VELOXIS PHARMACEUTICALS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Cary, NC
DK
DK
DK
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Julia Anne Matheson
Julia Anne Matheson Potomac Law Group, PLLC1300 Pennsylvania Avenue, NWSuite 700Washington, DC 20004Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations, namely, immunotherapeutic and immunosuppressive preparations for medical use for treatment of transplant patients; pharmaceutical preparations and drug delivery systems, pharmaceutical modified release systems, and pharmaceutical controlled release systems, comprised of tablets, granules, pills, sachets, powders, capsules, solutions or fluids, all of the above for use in the treatment of [ mental and ] physical disorders, emergencies and traumas, [ aging, allergy and immunology, ] burns, diseases of the heart and blood vessels, [ dental and gum diseases, skin diseases, nutritional and dietary diseases, diseases of the endocrinological system and pancreatic diseases, diabetes, epidemical diseases, diseases and afflictions of the gastroenterological system, diseases of the blood, infectious diseases, ] neurological diseases, [ nephrological diseases, diseases in the obstetrical and gynecological field, ] cancer [, ophthalmological diseases, diseases and afflictions affecting the bones, joints, cartilage material and muscles, diseases and afflictions of the ear, nose and throat, diseases and afflictions in the psychiatric field, pulmonological diseases and afflictions, rheumatism, urological diseases and afflictions and generalized pain ] | ACTIVE | — |
| 040 | [ Treatment of materials, namely, milling, grinding, mixing, compressing, and melting of pharmaceutical, medicinal, biotechnical and bacteriological substances, preparations, formulations and solutions, for use in the pharmaceutical and medical industries ] | SECTION 71 - CANCELLED | — |
| 041 | Education and training services, namely, arranging and conducting of seminars, workshops, conferences, lectures and congresses, all in the medical, chemical and pharmaceutical fields | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research, analysis and testing in the field of medical science, pharmacology, biotechnology and bacteriological areas and providing consultation and information relating thereto; design of drug delivery systems for medical use; conducting of tests regarding medical applications; packaging design for others; designing and development of medical equipment; designing pharmaceutical medical preparations; development of pharmaceutical formulations; design and development of granulation technology and tablet technology and providing consultation and information thereto; materials testing for the pharmaceutical and medical industries | ACTIVE | — |
| 044 | Medical and pharmaceutical assistance and consultation, namely, medical and pharmaceutical information services, namely, providing medical and scientific research information in the field of pharmaceuticals | ACTIVE | — |
| 045 | [ Consultancy services regarding intellectual property; licensing of intellectual property; medical and pharmaceutical assistance and consultation, including medical and pharmaceutical information services ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Veloxis Pharmaceuticals, Inc.
- Other trademarks owned by Veloxis Pharmaceuticals A/S
- Other trademarks owned by Veloxis Pharmaceuticals A/S
- Other trademarks owned by Veloxis Pharmaceuticals A/S
- Other trademarks in Class 005
- Other trademarks in Class 040
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named VELOXIS PHARMACEUTICALS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 8, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jul 21, 2023 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 14, 2023 | INPC | INVALIDATION PROCESSED | — |
| May 14, 2023 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 21, 2023 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Mar 21, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Mar 21, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 21, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 21, 2023 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Sep 14, 2022 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Sep 14, 2022 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Sep 12, 2022 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Sep 25, 2021 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Sep 18, 2021 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jul 22, 2021 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| May 21, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Feb 7, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 11, 2019 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Jun 22, 2019 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Jun 22, 2019 | INPC | INVALIDATION PROCESSED | — |
| May 29, 2019 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Sep 29, 2018 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Sep 29, 2018 | C75P | REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Sep 27, 2018 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Sep 24, 2018 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Sep 17, 2018 | CORR | CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED | — |
| Aug 3, 2018 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Jan 18, 2018 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 25, 2017 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jul 21, 2016 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 26, 2015 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Sep 11, 2014 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Mar 4, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 11, 2013 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 11, 2013 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Dec 25, 2012 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 25, 2012 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 23, 2012 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 10, 2012 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 10, 2012 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 20, 2012 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 20, 2012 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 20, 2012 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 1, 2012 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| May 31, 2012 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 31, 2012 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| May 31, 2012 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| May 31, 2012 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| May 31, 2012 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 30, 2012 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 30, 2012 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 22, 2012 | ALIE | ASSIGNED TO LIE | — |
| May 10, 2012 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 10, 2012 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 19, 2011 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 27, 2011 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 10, 2011 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 10, 2011 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Nov 8, 2011 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 8, 2011 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 7, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 3, 2011 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 2, 2011 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 1, 2011 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 1, 2011 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 28, 2011 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 28, 2011 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 27, 2011 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Oct 27, 2011 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |